Waters Corp (WAT)
NYSE: WAT · Diagnostics & Research · Milford, MA
Our rating: Neutral
Neutral reaffirmed at $470.90, moderate conviction, November 11, 2026.
Breaks if: The Neutral call turns Positive if Waters delivers revenue growth above 12% year-over-year for two consecutive quarterly prints, signaling demand is running well ahead of what the current price implies. It turns Cautious if revenue growth decelerates below 3% year-over-year for two straight quarters — at that pace, a 43.8x earnings multiple becomes genuinely difficult to defend regardless of franchise quality.
Key figures
| Market value | $43.3B |
|---|---|
| Revenue, last 12 months | $5.6B |
| Net income, last 12 months | $99M |
| Free cash flow, last 12 months | $291M |
| Price to earnings | 438.9× |
| Free cash flow yield | 0.7% |
| Dividend yield | 0.0% |
| Operating margin | 4.7% |
| Return on equity | 1.1% |
| Beta to the S&P 500 | 0.94 |
| Volatility, annualized | 36.7% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| October 3, 2026 | $1.8B | 120.9% | $0.82 | $54M |
| July 4, 2026 | $1.6B | 113.3% | $-1.39 | $153M |
| April 4, 2026 | $1.3B | 91.5% | $-0.87 | −$42M |
| December 31, 2025 | $932M | 6.8% | $3.77 | $126M |
| September 30, 2025 | $800M | 8.0% | $2.50 | $162M |
| June 30, 2025 | $771M | 8.9% | $2.47 | $18M |
| March 31, 2025 | $662M | 3.9% | $2.03 | $234M |
| December 31, 2024 | $873M | 6.5% | $3.88 | n/a |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $1.71B: Claude 72%, Gemini 90%, Mistral 85%
- Diluted earnings per share are at least $3.77: Claude 12%, Gemini 15%, Mistral 15%
- Free cash flow for the quarter is at least $0.13B: Claude 52%, Gemini 60%, Mistral 55%
- Backlog at the end of the quarter is at least $0.46B: Claude 38%, Gemini 25%, Mistral 35%
9 ledger entries and 46 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.